Kenya - English - Pharmacy and Poisons Board

shelys pharmaceuticals ltd. plot no. 696 new bagamoyo road mwenge p.o. box - zinc sulfate monohydrate usp - dispersible tablet - each dispersible tablet contains - zinc sulfate… - mineral supplements: zinc

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: euro generics international phils., inc; distributor: remed pharmaceuticals, inc. - zinc - tablet - 20 mg (equivalent to 57.645 mg zinc sulfate monohydrate)

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - pramipexole dihydrochloride (unii: 3d867np06j) (pramipexole - unii:83619peu5t) - pramipexole dihydrochloride 0.500 mg - mirapex® (pramipexole dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic parkinson's disease. the effectiveness of mirapex tablets was demonstrated in randomized, controlled trials in patients with early parkinson's disease who were not receiving concomitant levodopa therapy as well as in patients with advanced disease on concomitant levodopa (see clinical studies ). mirapex tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). key diagnostic criteria for rls are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or night. difficulty falling asleep may frequently be associated with symptoms of rls. mir

Philippines - English - FDA (Food And Drug Administration)

international pharmaceuticals, inc. - zinc oxide , benzoic acid , sulfur , salicylic acid - ointment - 12.90 g/ 4.50 g/ 3.40 g/ 1.87 g per 100 g

Philippines - English - FDA (Food And Drug Administration)

international pharmaceuticals inc - zinc oxide , benzoic acid , sulfur , salicylic acid - ointment - 12.90 g/ 4.50 g/ 3.40 g/ 1.87 g per 100 g

Philippines - English - FDA (Food And Drug Administration)

international pharmaceuticals, inc. - zinc oxide , benzoic acid , sulfur , salicylic acid - ointment - 12.90g/ 4.50g/ 3.40g/ 1.87g per 100g

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - vusion ointment is indicated for the adjunctive treatment of diaper dermatitis only when complicated by documented candidiasis (microscopic evidence of pseudohyphae and/or budding yeast), in immunocompetent pediatric patients 4 weeks and older. a positive fungal culture for candida albicans is not adequate evidence of candidal infection since colonization with c. albicans can result in a positive culture. the presence of candidal infection should be established by microscopic evaluation prior to initiating treatment. vusion should be used as part of a treatment regimen that includes measures directed at the underlying diaper dermatitis, including gentle cleansing of the diaper area and frequent diaper changes. vusion should not be used as a substitute for frequent diaper changes. the safety and efficacy of vusion have not been demonstrated in immunocompromised patients, or in infants less than 4 weeks of age (premature or term). the safety and efficacy of vusion have not been evaluated in incontinent adult

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - miconazole nitrate, zinc oxide and white petrolatum ointment is indicated for the adjunctive treatment of diaper dermatitis only when complicated by documented candidiasis (microscopic evidence of pseudohyphae and/or budding yeast), in immunocompetent pediatric patients 4 weeks and older. a positive fungal culture for candida albicans is not adequate evidence of candidal infection since colonization with c. albicans can result in a positive culture. the presence of candidal infection should be established by microscopic evaluation prior to initiating treatment. miconazole nitrate, zinc oxide and white petrolatum ointment should be used as part of a treatment regimen that includes measures directed at the underlying diaper dermatitis, including gentle cleansing of the diaper area and frequent diaper changes. miconazole nitrate, zinc oxide and white petrolatum ointment should not be used as a substitute for frequent diaper changes. the safety and efficacy of miconazole nitrate, zinc oxide and white petrolatum

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shelys pharmaceuticals limited, tanzania - zinc sulfate monohydrate - tablets - 20 mg

Philippines - English - FDA (Food And Drug Administration)

international apex pharmaceuticals, inc.; distributor: endure medical, inc. - enoxaparin sodium - solution for injection (sc) - 20mg + 0.2ml